Kyowa Hakko Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
|Company name||Kyowa Hakko Kirin Co., Ltd.|
|Establishment||July 1, 1949
*On October 1, 2008, KYOWA HAKKO KOGYO CO., LTD. changed its name to Kyowa Hakko Kirin Co., Ltd. following merger with Kirin Pharma Company, Limited.
|Capital||¥26,745,000,000 (As of December 31, 2015)|
|Number of employees||7,435 (Consolidated base, as of December 31, 2015)|
|Executive Director of the Board, President & Chief Executive Officer||Nobuo Hanai|
|Headquarters||Otemachi Building, 1-6-1 Otemachi, Chiyoda-ku, Tokyo 100-8185
|Business Offices In Japan||List of Locations|
|Main Business||Kyowa Hakko Kirin Co., Ltd. is engaged in the manufacturing and marketing of pharmaceuticals. As the holding company of the Kyowa Hakko Kirin Group, it manages the business activities in the Bio-Chemicals segment.|
|Parent Company||Kirin Holdings Company, Limited|
|Corporate Profile||Download (PDF：2.3MB)|